التفاصيل البيبلوغرافية
العنوان:
[Untitled]
المؤلفون:
Richard L. Miller , David M. Hammerbeck , Ikuhisa Yakuo , Kunihiko Takeyama , Mari Nogami-Itoh
المصدر:
Pharmaceutical Research . 14:208-212
بيانات النشر:
Springer Science and Business Media LLC, 1997.
سنة النشر:
1997
مصطلحات موضوعية:
Pharmacology , Chlorofluorocarbon , Inhalation , medicine.drug_class , Organic Chemistry , Pharmaceutical Science , Hydrofluoroalkane-134a , respiratory system , Dosage form , respiratory tract diseases , Bronchodilator Effect , chemistry.chemical_compound , chemistry , Anesthesia , Bronchodilator , Salbutamol , medicine , Molecular Medicine , Pharmacology (medical) , Histamine , circulatory and respiratory physiology , Biotechnology , medicine.drug
الوصف:
Purpose. The bronchodilator effect of salbutamol formulated in hydrofluoroalkane-134a (HFA-134a), a Chlorofluorocarbon (CFC)-free propellant for metered dose inhalation (MDI) devices, was compared with that of salbutamol formulated in CFC in anesthetized dogs.
تدمد:
0724-8741
الوصول الحر:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1e892015d9d6a0a7ac3b99e2ca6575eTest https://doi.org/10.1023/a:1012056928780Test
رقم الانضمام:
edsair.doi...........a1e892015d9d6a0a7ac3b99e2ca6575e
قاعدة البيانات:
OpenAIRE
